SMAD3 and cancer: It is likely that part of the mechanism by which hypoxia activates SMAD3 signaling involves autocrine production of TGFβ, as previous findings have indicated that hypoxia increases the expression of the TGFβ pro-protein convertase furin in cancer cells, resulting in enhanced processing and bioactivation of the TGFβ precursor form [34].